#transplant

Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.

Even with this increase, older individuals now have better transplant outcomes.

Yes! An Alabama program allows organs to be transplanted from donors with hepatitis C into recipients who don’t have the virus.

Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.

So far, the rise in COVID-related transplants has not dramatically affected the existing waiting lists for organs.

Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.

If you have hepatitis C or associated medical conditions, make your safety action plan to protect against cold, flu and COVID-19.

Researchers suggest the process is safe and may help reduce alcohol cravings.

Especially from people who might have been considered a risk for transmitting HIV and hepatitis B and C

47 Americans have donated more than one organ to two different people.

The drug is still associated with a lower liver cancer rate than Baraclude.

The opioid epidemic is likely fueling increased rates of deceased organ donors categorized as posing a high risk of passing on such viruses.

A recent study found that transplanting such kidneys and then treating the recipient for hep C worked well.

Jackie Johnson was diagnosed with hepatitis C in 2010. But in 2015, he took advantage of the latest hep C treatments and was soon cured.